Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 72Multiple Myeloma 70Leukemia, Myeloid, Acute 70Lymphoma, Large B-Cell, Diffuse 61Lymphoma, Non-Hodgkin 58Leukemia, Lymphocytic, Chronic, B-Cell 57Lymphoma 56Melanoma 52Leukemia 52Breast Neoplasms 49Burkitt Lymphoma 48Myelodysplastic Syndromes 44Recurrence 41Lymphoma, Follicular 41Lymphoma, B-Cell 38Lymphoma, Mantle-Cell 37Ovarian Neoplasms 32Neuroblastoma 32Lymphoma, B-Cell, Marginal Zone 27Sarcoma 26Neoplasms 26Carcinoma, Non-Small-Cell Lung 25Hodgkin Disease 24Neoplasm Metastasis 23Triple Negative Breast Neoplasms 18Carcinoma, Renal Cell 18Neoplasms, Plasma Cell 17Hematologic Neoplasms 17Leukemia, Myelomonocytic, Chronic 16Colorectal Neoplasms 16

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3Specimen Handling 3Magnetic Resonance Spectroscopy 3interferon alfa-n1 2cabozantinib 2Nivolumab 2Cyclophosphamide 2Biopsy 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1ibrutinib 1fludarabine 1efineptakin alfa 1axicabtagene ciloleucel 1Zalcitabine 1Vorinostat 1Tumor Necrosis Factor-alpha 1Transplantation Conditioning 1Taxes 1Sunitinib 1Polymerase Chain Reaction 1Pentoxifylline 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × HIV Infections × Cyclophosphamide × Clear all
NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡